Filed: 11/14/2023ACC: 0001420506-23-002213
๐ What this filing means
BRAIDWELL LP filed this quarterly 13FโHR report disclosing 86 equity positions with a total reported market value of $3.16B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
86
Positions
$3.16B
Total AUM (reported)
1.89B
Total Shares
Allocation by class
COM$1.40B44.2%
NOTE 11/1$185.76M5.9%
NOTE 11/0$118.01M3.7%
NOTE 2.250% 4/0$113.77M3.6%
NOTE 0.375% 3/0$113.72M3.6%
NOTE 2.625% 3/0$112.37M3.6%
NOTE 2.500% 3/1$109.76M3.5%
Portfolio Concentration
Top 3$417.55M13.2%
4โ10$701.19M22.2%
11โ25$762.64M24.1%
Rest$1.28B40.5%
Top 3 weight
13.2%
Top 10 weight
35.4%
Voting Authority Distribution
Total shares with voting rights: 1.89B
Sole
Full voting authority
1.89B
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole86
Shared0
Other0
Dominant voting typeSole ยท 100.0% of voting shares
Institutional Holdings86
Rows:
GUARDANT HEALTH INC
SOLEShares268.25M
TypePRN
Market value$185.76M
5.87%
Sole
268.25M
Shared
0.00
None
0.00
NOVOCURE LTD
SOLEShares135.83M
TypePRN
Market value$118.01M
3.73%
Sole
135.83M
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares124M
TypePRN
Market value$113.77M
3.60%
Sole
124M
Shared
0.00
None
0.00
EXACT SCIENCES CORP
SOLEShares131M
TypePRN
Market value$113.72M
3.59%
Sole
131M
Shared
0.00
None
0.00
NANOSTRING TECHNOLOGIES INC
SOLEShares145.52M
TypePRN
Market value$112.37M
3.55%
Sole
145.52M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares114.34M
TypePRN
Market value$109.76M
3.47%
Sole
114.34M
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares968.02K
TypeSH
Market value$108.90M
3.44%
Sole
968.02K
Shared
0.00
None
0.00
NEVRO CORP
SOLEShares109.25M
TypePRN
Market value$102.02M
3.22%
Sole
109.25M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares1.62M
TypeSH
Market value$82.56M
2.61%
Sole
1.62M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares2.10M
TypeSH
Market value$71.85M
2.27%
Sole
2.10M
Shared
0.00
None
0.00
BOSTON SCIENTIFIC CORP
SOLEShares1.16M
TypeSH
Market value$61.50M
1.94%
Sole
1.16M
Shared
0.00
None
0.00
LEGEND BIOTECH CORP
SOLEShares879.56K
TypeSH
Market value$59.08M
1.87%
Sole
879.56K
Shared
0.00
None
0.00
NUVASIVE INC
SOLEShares61.34M
TypePRN
Market value$56.65M
1.79%
Sole
61.34M
Shared
0.00
None
0.00
INSULET CORP
SOLEShares54.50M
TypePRN
Market value$53.57M
1.69%
Sole
54.50M
Shared
0.00
None
0.00
IRHYTHM TECHNOLOGIES INC
SOLEShares568.16K
TypeSH
Market value$53.55M
1.69%
Sole
568.16K
Shared
0.00
None
0.00
GLAUKOS CORP
SOLEShares695.79K
TypeSH
Market value$52.36M
1.65%
Sole
695.79K
Shared
0.00
None
0.00
IONIS PHARMACEUTICALS INC
SOLEShares52.74M
TypePRN
Market value$51.76M
1.64%
Sole
52.74M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares67.29M
TypePRN
Market value$50.47M
1.59%
Sole
67.29M
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares44.17M
TypePRN
Market value$49.55M
1.57%
Sole
44.17M
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares56.03M
TypePRN
Market value$48.22M
1.52%
Sole
56.03M
Shared
0.00
None
0.00
IMMUNOCORE HLDGS PLC
SOLEShares906.97K
TypeSH
Market value$47.07M
1.49%
Sole
906.97K
Shared
0.00
None
0.00
DAY ONE BIOPHARMACEUTICALS I
SOLEShares3.72M
TypeSH
Market value$45.59M
1.44%
Sole
3.72M
Shared
0.00
None
0.00
NEOGENOMICS INC
SOLEShares62.60M
TypePRN
Market value$45.19M
1.43%
Sole
62.60M
Shared
0.00
None
0.00
NATERA INC
SOLEShares1.01M
TypeSH
Market value$44.79M
1.42%
Sole
1.01M
Shared
0.00
None
0.00
KEROS THERAPEUTICS INC
SOLEShares1.36M
TypeSH
Market value$43.27M
1.37%
Sole
1.36M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting โ Sole | Shared | None |
|---|---|---|---|---|---|---|---|
GUARDANT HEALTH INCSOLE | NOTE 11/1 | 268.25M | PRN | $185.76M 5.87% | 268.25M | 0.00 | 0.00 |
NOVOCURE LTDSOLE | NOTE 11/0 | 135.83M | PRN | $118.01M 3.73% | 135.83M | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | NOTE 2.250% 4/0 | 124M | PRN | $113.77M 3.60% | 124M | 0.00 | 0.00 |
EXACT SCIENCES CORPSOLE | NOTE 0.375% 3/0 | 131M | PRN | $113.72M 3.59% | 131M | 0.00 | 0.00 |
NANOSTRING TECHNOLOGIES INCSOLE | NOTE 2.625% 3/0 | 145.52M | PRN | $112.37M 3.55% | 145.52M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | NOTE 2.500% 3/1 | 114.34M | PRN | $109.76M 3.47% | 114.34M | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 968.02K | SH | $108.90M 3.44% | 968.02K | 0.00 | 0.00 |
NEVRO CORPSOLE | NOTE 2.750% 4/0 | 109.25M | PRN | $102.02M 3.22% | 109.25M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 1.62M | SH | $82.56M 2.61% | 1.62M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 2.10M | SH | $71.85M 2.27% | 2.10M | 0.00 | 0.00 |
BOSTON SCIENTIFIC CORPSOLE | COM | 1.16M | SH | $61.50M 1.94% | 1.16M | 0.00 | 0.00 |
LEGEND BIOTECH CORPSOLE | SPONSORED ADS | 879.56K | SH | $59.08M 1.87% | 879.56K | 0.00 | 0.00 |
NUVASIVE INCSOLE | NOTE 0.375% 3/1 | 61.34M | PRN | $56.65M 1.79% | 61.34M | 0.00 | 0.00 |
INSULET CORPSOLE | NOTE 0.375% 9/0 | 54.50M | PRN | $53.57M 1.69% | 54.50M | 0.00 | 0.00 |
IRHYTHM TECHNOLOGIES INCSOLE | COM | 568.16K | SH | $53.55M 1.69% | 568.16K | 0.00 | 0.00 |
GLAUKOS CORPSOLE | COM | 695.79K | SH | $52.36M 1.65% | 695.79K | 0.00 | 0.00 |
IONIS PHARMACEUTICALS INCSOLE | NOTE 4/0 | 52.74M | PRN | $51.76M 1.64% | 52.74M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | NOTE 2.250% 2/0 | 67.29M | PRN | $50.47M 1.59% | 67.29M | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | NOTE 1.250% 9/1 | 44.17M | PRN | $49.55M 1.57% | 44.17M | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | NOTE 2.500% 9/1 | 56.03M | PRN | $48.22M 1.52% | 56.03M | 0.00 | 0.00 |
IMMUNOCORE HLDGS PLCSOLE | ADS | 906.97K | SH | $47.07M 1.49% | 906.97K | 0.00 | 0.00 |
DAY ONE BIOPHARMACEUTICALS ISOLE | COM | 3.72M | SH | $45.59M 1.44% | 3.72M | 0.00 | 0.00 |
NEOGENOMICS INCSOLE | NOTE 0.250% 1/1 | 62.60M | PRN | $45.19M 1.43% | 62.60M | 0.00 | 0.00 |
NATERA INCSOLE | COM | 1.01M | SH | $44.79M 1.42% | 1.01M | 0.00 | 0.00 |
KEROS THERAPEUTICS INCSOLE | COM | 1.36M | SH | $43.27M 1.37% | 1.36M | 0.00 | 0.00 |
Page 1 of 4